Rigel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $55,307 | $36,841 | $29,534 | $35,792 |
Gross Profit | 47,281 | 34,034 | 27,509 | 32,002 |
EBITDA | 15,092 | 1,060 | -5,973 | 2,937 |
EBIT | 14,481 | 447 | -6,373 | 2,644 |
Net Income | 12,421 | -1,030 | -8,247 | 737 |
Net Change In Cash | 55,307 | 36,841 | 29,534 | 35,792 |
Free Cash Flow | 22,029 | 80 | -5,151 | -6,350 |
Cash | 51,692 | 36,053 | 25,574 | 32,786 |
Basic Shares | 17,648 | 17,549 | 17,520 | 17,446 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $116,882 | $120,242 | $149,236 | $108,621 |
Gross Profit | 109,772 | 118,493 | 148,153 | 107,726 |
EBITDA | -16,981 | -53,868 | -11,287 | -27,685 |
EBIT | -18,219 | -54,866 | -12,449 | -28,391 |
Net Income | -25,091 | -61,596 | -17,914 | -30,391 |
Net Change In Cash | 116,882 | 120,242 | 149,236 | 108,621 |
Cost of Revenue | 5,569 | -11,483 | 7,852 | |
Free Cash Flow | -20,743 | -74,208 | 5,251 | -53,447 |
Cash | 32,786 | 24,459 | 18,890 | 30,373 |
Basic Shares | 17,401 | 17,240 | 17,049 | 16,875 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.70 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.05 |
2023-12-31 | $0.004 |
